Takeda Oncology
在场
Takeda Oncology 的所有者是 Takeda Pharmaceutical.
是其中之一......
Takeda Pharmaceutical 是一家在股票代码 4502 (JP) 下上市的公司。
Takeda Pharmaceutical 在 20 个国家有直接业务。Takeda Pharmaceutical 拥有 21家子公司，其中包括 Takeda Americas、Takeda APAC 和 Takeda Australia。
他们在：
高管
查看带有其 19 名主要高管的组织结构图
Takeda Oncology 搜索最多的简介
- Teresa Bitetti, President
- Liz Lewis, Head of Global Patient Value, Policy and Access
- Cristin McArdle, Head, Counsel
高管在Takeda Pharmaceutical变化
- Olivier Bohuon, Director, 已经去世。我们深感遗憾 (新闻发布的2024五月10号).
创建提醒
跟踪 Takeda Oncology 的高管变动
药店
Takeda Pharmaceutical 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Takeda Oncology 的最新新闻稿
- 404 Page404 Page
- 404 Page404 Page
- 404 Page404 Page
- 404 Page404 Page
- Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease | Takeda Oncology
- Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress | Takeda Oncology
- Foundation Medicine and Takeda Announce Collaboration To Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for Takeda’s Late-Stage Lung Cancer Portfolio | Takeda Oncology
- Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs | Takeda Oncology
- Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma | Takeda Oncology
- Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS) | Takeda Oncology
- View more press releases Close
通过电子邮件
